CME: Myelodysplastic Syndromes (MDS): Highlights from the 2013 American Society of Hematology Take-Aways, Emerging Practice Changes, and Barriers to their Implementation
ACCREDITATION EXPIRED: March 25, 2016
Activity Description / Statement of Need:
In this online CME self-learning program:
Annual meetings of large, national, professional societies offer an opportunity for healthcare professionals to get a first glimpse at study results that have the potential to impact practice as provide a forum for an exchange of ideas and practices between thought leaders and less distinguished practitioners. The 2013 American Society of Hematology Annual Meeting (ASH 2013) is no exception. Nevertheless, as with every meeting, many professionals from both the community and health-system settings alike will be unable to attend the conference for a variety of reasons, justifying the creation of educational programming that summarize the major findings presented at the meeting.
Engendering a blended approach of ASH 2013 synopses and their application to sample patient cases, this program has been designed to update healthcare professionals’ knowledge around the current state of care in the aforementioned disease states and improve their competence and performance in treating them.
Agenda
|
- Faculty member introduction, disclosures |
|
- Major findings from ASH 2013, including clinical trial data relevant to both community and health-system practice and recognized barriers to implementing those findings in practice |
|
- Application: patient cases |
|
- Summary, conclusion, and best practice recap |
Target Audience:
Hematologist-oncologists, oncology nurse practitioners, physician assistants who specialize in oncology, oncology nurses, and any other healthcare professionals who otherwise come into regular clinical contact with or provide care for patients with myelodysplastic syndromes (MDS).
Commercial Support Disclosure: This program is supported by educational grants from Incyte Pharmaceuticals.
Release Date: March 25, 2014 -- Expiration Date: March 25, 2016
Faculty: Guillermo Garcia-Manero, MD
Agenda
Learning Objectives
By the end of the session the participant will be able to:
- Summarize the most impactful findings presented at ASH 2013 relating to myelodysplastic syndromes (MDS) and apply them to patient cases, taking into account any relevant barriers to care.
Accreditation
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
Faculty Disclosure and Resolution of COI
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Faculty Disclosure: Guillermo Garcia-Maner, MD has no relevent financial discloses..
Disclosures of Educational Planners: Charles Turck, PharmD is an officer and part owner of ScientiaCME, LLC.
Commercial Support Disclosure: This program is supported by educational grants from Incyte Pharmaceuticals.
Instructions
- Read the learning objectives above
- Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
- View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
- Minimum participation threshold: Take the post-test. A score of 70% or higher is required to pass and proceed to the activity evaluation.
- Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.
System Requirements
Windows 7 or above
Internet Explorer 8
*Adobe Acrobat Reader
Mac OS 10.2.8
Safari or Chrome or Firefox
*Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.